HOUSTON / Oct 23, 2024 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2024, on Tuesday, November 5, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, November 6, 2024.
Conference Call | Date: | Wednesday, November 6, 2024 |
Time: | 10:30 am Eastern/9:30 am Central | |
Dial-In Number: | (800) 245-3047 Primary or | |
(203) 518-9765 Alternate | ||
Conference ID: | USPHQ324 | |
(In order to join this conference call, you will be required to provide the Conference ID listed above)
| ||
To participate, please call in 15 minutes prior to start time. | ||
To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until February 4, 2025, at U.S. Physical Therapy’s website.
About U.S. Physical Therapy, Inc.
Founded in 1990, U.S. Physical Therapy, Inc. operates approximately 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 39 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention services business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
More information about U.S. Physical Therapy, Inc. is available at www.usph.com The information included on that website is not incorporated into this press release.
| Last Trade: | US$68.45 |
| Daily Change: | -1.16 -1.67 |
| Daily Volume: | 95,413 |
| Market Cap: | US$1.030B |
March 03, 2025 February 26, 2025 December 02, 2024 November 12, 2024 November 05, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
